Home » Topics » BioWorld Science

BioWorld Science
RSS

ZDWX-25, GSK-3beta/DYRK1A dual inhibitor with promising activity in models of AD

Sep. 15, 2021

JUN identified as a crucial regulator of pathological skin scarring via CD36

Sep. 15, 2021

CD39+ plasmablasts and adenosine identified as drivers of sepsis-induced long-term immunosuppression

Sep. 15, 2021

Bahcesehir Universitesi presents new Hdm2 inhibitors

Sep. 15, 2021

Mitochondrial-encoded MOTS-c as novel therapeutic target in autoimmune diabetes

Sep. 15, 2021

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Sep. 15, 2021

Preclinical data presented for HIF-1 inhibitor LW-1564

Sep. 15, 2021

Kinnate presents preclinical data on next-generation pan-FGFR inhibitor KIN-3248

Sep. 14, 2021

Satellos reports preclinical data on drug candidate in mouse model of DMD

Sep. 14, 2021

Strong nectin-4 expression tied to poor prognosis in UTUC

Sep. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...